Trailing-twelve-month (TTM) revenue is $765.67 Million with a year-over-year growth of +16.37%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $198,936,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-28 | $213,552,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-29 | $187,155,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-28 | $166,029,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $765,672,000 |
Current P/S: $402,775,900 market capitalization ÷ $765,672,000 TTM revenue = 0.53x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-28): $166.03M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:58:37.852Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-27 · USD | FY20212021-12-26 · USD | FY20222022-12-25 · USD | FY20232023-12-31 · USD | FY20242024-12-29 · USD | FY20252025-12-28 · USD |
|---|---|---|---|---|---|---|
| Butter And Butter Related Products | $18M | $21M | $23M | $23M | $25M | $26M |
| Egg And Egg Related | $197M | N/A | N/A |
$765.67M
$765.67 Million
+16.37%
vs. $657.96M a year ago (TTM)
+27.60%
5 Year compound annual growth rate
1 Year
+16.37%
3 Year
+21.35%
5 Year
+27.60%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $759.44M | +$153.14M | +25.26% |
| 2024 | $606.31M | +$134.45M | +28.49% |
| 2023 | $471.86M | +$109.81M | +30.33% |
| 2022 | $362.05M | +$101.15M | +38.77% |
| 2021 | $260.90M | +$46.62M | +21.76% |
| 2020 |
TTM Growth
+16.37%
3-Year CAGR
+21.35%
5-Year CAGR
+27.60%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:58:37.852Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| N/A |
| N/A |
| N/A |
| Eggs And Egg Related Products | N/A | $240M | $339M | $449M | $581M | $733M |
|---|
| $214.28M |
| +$73.55M |
| +52.26% |
| 2019 | $140.73M | +$34.02M | +31.88% |
| 2018 | $106.71M | +$32.71M | +44.21% |
